GlassScriptPhysician profile
David P Beckmann
NPI 1407015704
$10,985.01
in general payments reported to CMS, 2019-2025
52 companies · $2,335 in 2025
The $2,335 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,095 · 2020: $773 · 2021: $1,832 · 2022: $1,805 · 2023: $1,482 · 2024: $1,664 · 2025: $2,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,480.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,516.29 | 2019-2025 | |
| Novo Nordisk INC | $1,294.86 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $1,195.80 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $1,097.13 | 2020-2025 | Vraylar |
| Lilly USA, LLC | $1,088.21 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $990.05 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $380.73 | 2021-2025 | |
| Astellas Pharma US INC | $276.80 | 2021-2025 | Veozah |
| Otsuka America Pharmaceutical, INC. | $242.71 | 2023-2025 | Rexulti |
| Amgen INC. | $226.50 | 2020-2025 | Otezla, Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $206.39 | 2019-2022 | |
| Cranial Technologies, INC | $184.27 | 2019-2025 | Doc Band |
| Allergan, INC. | $161.56 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $158.73 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $151.87 | 2022 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $148.29 | 2020-2025 | Xifaxan |
| Vanda Pharmaceuticals INC. | $115.91 | 2024-2025 | Fanapt |
| Exact Sciences Corporation | $111.75 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Radius Health, INC. | $106.19 | 2024-2025 | Tymlos |
| Biohaven Pharmaceuticals, INC. | $101.02 | 2021 | |
| Exeltis, USA INC. | $96.79 | 2020-2025 | Slynd |
| Organon LLC | $89.95 | 2021-2025 | Nexplanon |
| Qiagen, LLC | $80.11 | 2019 | |
| Janssen Pharmaceuticals, INC | $77.87 | 2024-2025 | Spravato |
| Abbott Laboratories | $72.72 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $60.39 | 2025 | Caplyta |
| Esperion Therapeutics, INC. | $59.81 | 2021 | |
| Ethicon US, LLC | $55.46 | 2025 | Stratafix |
| Agile Therapeutics, INC. | $54.96 | 2021-2024 | Twirla |
| Corcept Therapeutics | $50.37 | 2023-2025 | Korlym |
| Sobi, INC | $46.72 | 2022 | |
| Merck Sharp & Dohme LLC | $43.50 | 2024 | Capvaxive, Vaxneuvance, Vaxelis |
| Axsome Therapeutics, INC. | $43.00 | 2025 | Auvelity |
| Si-Bone, INC. | $32.63 | 2021 | |
| Sumitomo Pharma America, INC. | $28.77 | 2023 | Myfembree |
| Medtronic, INC. | $28.02 | 2023 | Interstim |
| Sanofi Pasteur INC. | $25.18 | 2019-2020 | |
| Inspire Medical Systems, INC. | $24.98 | 2025 | Inspire |
| Therapeuticsmd, INC. | $24.23 | 2020-2021 | |
| Amarin Pharma, INC. | $22.74 | 2021 | |
| Edwards Lifesciences Corporation | $21.23 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Echosens North America, INC. | $20.60 | 2025 | Fibroscan |
| Mylan Specialty L.P. | $20.50 | 2019 | |
| Mylan Pharmaceuticals INC. | $19.72 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $19.09 | 2025 | Eliquis |
| Hologic Sales and Service, LLC | $18.76 | 2024 | Aptima |
| Dexcom, INC. | $18.47 | 2025 | Dexcom G6 Transmitter |
| Aspira Women'S Health INC | $16.27 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.18 | 2021 | |
| Currax Pharmaceuticals LLC | $14.84 | 2025 | Contrave |
| Scynexis, INC. | $13.73 | 2022 | |
| Bausch Health US, LLC | $13.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Beckmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.